Company · CIK 0001510580 · SIC 2836 — Biological Products, (No Diagnostic Substances)
Kite Pharma, Inc. · KITE
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 3, 2017 DUForm 4 → | Oct 5, 8:27 pm EDT | Ian T ClarkDirector | 7,100 | $180.00 | $319,680 | 0 | — | plan? |
| Oct 3, 2017 DForm 4 → | Oct 5, 8:26 pm EDT | Ran NussbaumDirector | 14,192 | — | — | 0 | — | plan? |
| Oct 3, 2017 DUForm 4 → | Oct 5, 8:24 pm EDT | Franz B HumerDirector | 6,431 | $180.00 | $832,320 | 0 | — | plan? |
| Oct 3, 2017 DUForm 4 → | Oct 5, 8:23 pm EDT | Roy DoumaniDirector | 177,492 | $180.00 | $31,623,300 | 0 | — | plan? |
| Oct 3, 2017 DForm 4 → | Oct 5, 8:22 pm EDT | David BondermanDirector | 2,412,444 | — | — | 0 | — | plan? |
| Oct 3, 2017 DUForm 4 → | Oct 5, 8:17 pm EDT | Timothy L. MooreEVP, Technical Operations | 45,661 | $180.00 | $706,860 | 0 | — | plan? |
| Oct 3, 2017 DUForm 4 → | Oct 5, 8:15 pm EDT | Jeffrey WiezorekSVP Clinical Development | 25,824 | $180.00 | $2,641,320 | 0 | — | plan? |
| Oct 3, 2017 DUForm 4 → | Oct 5, 8:14 pm EDT | Helen Susan KimEVP, Business Development | 21,693 | $180.00 | $754,740 | 0 | — | plan? |
| Oct 3, 2017 DForm 4 → | Oct 5, 8:13 pm EDT | Paul L JenkinsonChief Financial Officer | 12,462 | $180.00 | $540,000 | 0 | — | plan? |
| Sep 29, 2017 DGUForm 4 → | Oct 5, 8:20 pm EDT | Farah ChampsiDirector | 66,074 | $180.00 | $11,064,060 | 0 | — | plan? late |
| Sep 28, 2017 DJUForm 4 → | Oct 5, 8:25 pm EDT | Joshua A KazamDirector | 144,460 | $180.00 | $13,068,540 | 0 | — | plan? late |
| Sep 25, 2017 DGUForm 4 → | Oct 5, 8:16 pm EDT | Shawn TomaselloChief Commercial Officer | 61,068 | $180.00 | $2,904,300 | 0 | — | plan? late |
| Sep 25, 2017 ADForm 4 → | Oct 5, 8:10 pm EDT | Arie BelldegrunChairman, President and CEO, Director | 3,406,429 | $180.00 | $575,508,420 | 0 | — | plan? late |
| Sep 25, 2017 SForm 4 → | Sep 27, 9:44 pm EDT | Shawn TomaselloChief Commercial Officer | 4,203 | $179.66 | $755,127 | 61,068 | −6.44% | plan? |
| Sep 25, 2017 AForm 4 → | Sep 27, 9:44 pm EDT | Shawn TomaselloChief Commercial Officer | 4,500 | — | — | 65,271 | — | plan? |
| Sep 25, 2017 SForm 4 → | Sep 27, 9:43 pm EDT | Helen Susan KimEVP, Business Development | 3,171 | $179.66 | $569,714 | 21,693 | −12.8% | plan? |
| Sep 25, 2017 AForm 4 → | Sep 27, 9:43 pm EDT | Helen Susan KimEVP, Business Development | 6,000 | — | — | 24,864 | — | plan? |
| Sep 25, 2017 AForm 4 → | Sep 27, 9:42 pm EDT | Timothy L. MooreEVP, Technical Operations | 8,000 | — | — | 49,889 | — | plan? |
| Sep 25, 2017 SForm 4 → | Sep 27, 9:41 pm EDT | Jeffrey WiezorekSVP Clinical Development | 5,283 | $179.66 | $949,164 | 25,824 | −17.0% | plan? |
| Sep 25, 2017 AForm 4 → | Sep 27, 9:41 pm EDT | Jeffrey WiezorekSVP Clinical Development | 10,000 | — | — | 31,107 | — | plan? |
| Sep 25, 2017 SForm 4 → | Sep 27, 9:40 pm EDT | David D ChangEVP, R&D, Chief Medical Off. | 7,927 | $179.66 | $1,424,196 | 57,423 | −12.1% | plan? |
| Sep 25, 2017 AForm 4 → | Sep 27, 9:40 pm EDT | David D ChangEVP, R&D, Chief Medical Off. | 15,000 | — | — | 65,350 | — | plan? |
| Sep 25, 2017 SForm 4 → | Sep 27, 9:39 pm EDT | Paul L JenkinsonChief Financial Officer | 948 | $179.66 | $170,321 | 9,462 | −9.11% | plan? |
| Sep 25, 2017 AForm 4 → | Sep 27, 9:39 pm EDT | Paul L JenkinsonChief Financial Officer | 2,500 | — | — | 10,410 | — | plan? |
| Sep 25, 2017 SForm 4 → | Sep 27, 9:38 pm EDT | Cynthia M ButittaChief Operating Officer | 4,228 | $179.66 | $759,619 | 121,567 | −3.36% | plan? |
| Sep 25, 2017 AForm 4 → | Sep 27, 9:38 pm EDT | Cynthia M ButittaChief Operating Officer | 8,000 | — | — | 125,795 | — | plan? |
| Sep 25, 2017 SForm 4 → | Sep 27, 9:38 pm EDT | Arie BelldegrunChairman, President and CEO, Director | 26,347 | $179.66 | $4,733,605 | 109,160 | −19.4% | plan? |
| Sep 25, 2017 AForm 4 → | Sep 27, 9:38 pm EDT | Arie BelldegrunChairman, President and CEO, Director | 50,000 | — | — | 135,507 | — | plan? |
| Sep 21, 2017 DGForm 4 → | Oct 5, 8:11 pm EDT | Cynthia M ButittaChief Operating Officer | 121,567 | — | — | 0 | — | plan? late |
| Sep 18, 2017 DGUForm 4 → | Oct 5, 8:19 pm EDT | Owen N. WitteDirector | 76,250 | $180.00 | $10,536,300 | 0 | — | plan? late |
| Sep 14, 2017 DGForm 4 → | Oct 5, 8:21 pm EDT | Steven B RuchefskyDirector | 207,836 | — | — | 0 | — | plan? late |
| Sep 13, 2017 DGUForm 4 → | Oct 5, 8:28 pm EDT | Jonathan M PeacockDirector | 70,374 | $180.00 | $12,227,760 | 0 | — | plan? late |
| Sep 11, 2017 DGUForm 4 → | Oct 5, 8:12 pm EDT | David D ChangEVP, R&D, Chief Medical Off. | 57,423 | $180.00 | $2,988,900 | 0 | — | plan? late |
| Aug 10, 2017 SForm 4 → | Aug 14, 5:04 pm EDT | Helen Susan KimEVP, Business Development | 6,251 | $120.09 | $750,683 | 18,664 | −25.1% | plan? |
| Aug 10, 2017 MForm 4 → | Aug 14, 5:04 pm EDT | Helen Susan KimEVP, Business Development | 6,251 | $52.85 | $330,369 | 24,915 | — | plan? |
| Aug 10, 2017 SForm 4 → | Aug 14, 5:03 pm EDT | Cynthia M ButittaChief Operating Officer | 15,000 | $120.72 | $1,810,758 | 117,795 | −11.3% | plan? |
| Aug 10, 2017 MForm 4 → | Aug 14, 5:03 pm EDT | Cynthia M ButittaChief Operating Officer | 15,000 | $1.35 | $20,250 | 132,795 | — | plan? |
| Aug 8, 2017 SForm 4 → | Aug 10, 4:57 pm EDT | Helen Susan KimEVP, Business Development | 79,949 | $119.56 | $9,558,324 | 18,664 | −81.1% | plan? |
| Aug 8, 2017 MForm 4 → | Aug 10, 4:57 pm EDT | Helen Susan KimEVP, Business Development | 79,949 | $53.90 | $4,309,251 | 98,613 | — | plan? |
| Aug 3, 2017 SForm 4 → | Aug 4, 7:50 pm EDT | Timothy L. MooreEVP, Technical Operations | 6,000 | $110.06 | $660,343 | 49,400 | −10.8% | plan? |
| Aug 3, 2017 MForm 4 → | Aug 4, 7:50 pm EDT | Timothy L. MooreEVP, Technical Operations | 6,000 | $44.91 | $269,460 | 55,400 | — | plan? |
| Aug 1, 2017 SForm 4 → | Aug 3, 9:14 pm EDT | Timothy L. MooreEVP, Technical Operations | 12,000 | $107.69 | $1,292,322 | 49,400 | −19.5% | plan? |
| Aug 1, 2017 MForm 4 → | Aug 3, 9:14 pm EDT | Timothy L. MooreEVP, Technical Operations | 3,000 | $44.91 | $134,730 | 61,400 | — | plan? |
| Jul 31, 2017 SForm 4 → | Aug 1, 7:00 pm EDT | Helen Susan KimEVP, Business Development | 26,649 | $109.28 | $2,912,272 | 18,664 | −58.8% | plan? |
| Jul 31, 2017 MForm 4 → | Aug 1, 7:00 pm EDT | Helen Susan KimEVP, Business Development | 26,649 | $52.96 | $1,411,437 | 45,313 | — | plan? |
| Jul 10, 2017 SForm 4 → | Jul 11, 5:36 pm EDT | Cynthia M ButittaChief Operating Officer | 15,000 | $103.09 | $1,546,300 | 117,795 | −11.3% | plan? |
| Jul 10, 2017 MForm 4 → | Jul 11, 5:36 pm EDT | Cynthia M ButittaChief Operating Officer | 15,000 | $1.35 | $20,250 | 132,795 | — | plan? |
| Jul 3, 2017 SForm 4 → | Jul 6, 6:15 pm EDT | Jeffrey WiezorekSVP Clinical Development | 10,000 | $104.32 | $1,043,201 | 21,071 | −32.2% | plan? |
| Jul 3, 2017 MForm 4 → | Jul 6, 6:15 pm EDT | Jeffrey WiezorekSVP Clinical Development | 10,000 | $6.89 | $68,900 | 31,071 | — | plan? |
| Jun 23, 2017 SForm 4/A → | Jun 27, 7:07 pm EDT | Cynthia M ButittaChief Operating Officer | 5,000 | $100.81 | $504,033 | 117,795 | −4.07% | plan? |
| Jun 23, 2017 MForm 4/A → | Jun 27, 7:07 pm EDT | Cynthia M ButittaChief Operating Officer | 5,000 | $1.35 | $6,750 | 122,795 | — | plan? |
| Jun 23, 2017 SForm 4 → | Jun 27, 12:25 pm EDT | Cynthia M ButittaChief Operating Officer | 5,000 | $100.81 | $504,033 | 112,795 | −4.24% | plan? amended |
| Jun 23, 2017 SForm 4 → | Jun 26, 7:55 pm EDT | Owen N. WitteDirector | 25,000 | $100.30 | $2,507,500 | 76,250 | −24.7% | plan? |
| Jun 23, 2017 MForm 4 → | Jun 26, 7:55 pm EDT | Owen N. WitteDirector | 12,500 | $18.00 | $225,000 | 101,250 | — | plan? |
| Jun 20, 2017 AForm 4 → | Jun 22, 2:49 pm EDT | Farah ChampsiDirector | 2,410 | — | — | 66,074 | — | plan? |
| Jun 20, 2017 AForm 4 → | Jun 22, 2:48 pm EDT | David BondermanDirector | 2,410 | — | — | 4,360 | — | plan? |
| Jun 20, 2017 AForm 4 → | Jun 22, 2:47 pm EDT | Ian T ClarkDirector | 2,410 | — | — | 7,100 | — | plan? |
| Jun 20, 2017 AForm 4 → | Jun 22, 2:44 pm EDT | Roy DoumaniDirector | 2,410 | — | — | 152,427 | — | plan? |
| Jun 20, 2017 AForm 4 → | Jun 22, 2:39 pm EDT | Franz B HumerDirector | 2,410 | — | — | 6,431 | — | plan? |
| Jun 20, 2017 AForm 4 → | Jun 22, 2:38 pm EDT | Joshua A KazamDirector | 2,410 | — | — | 4,360 | — | plan? |
| Jun 20, 2017 AForm 4 → | Jun 22, 2:37 pm EDT | Ran NussbaumDirector | 2,410 | — | — | 4,360 | — | plan? |
| Jun 20, 2017 AForm 4 → | Jun 22, 2:35 pm EDT | Steven B RuchefskyDirector | 2,410 | — | — | 207,836 | — | plan? |
| Jun 20, 2017 AForm 4 → | Jun 22, 2:34 pm EDT | Jonathan M PeacockDirector | 2,410 | — | — | 70,374 | — | plan? |
| Jun 20, 2017 AForm 4 → | Jun 22, 2:33 pm EDT | Owen N. WitteDirector | 2,410 | — | — | 88,750 | — | plan? |
| Jun 14, 2017 SForm 4 → | Jun 16, 5:43 pm EDT | Steven B RuchefskyDirector | 20,000 | $89.48 | $1,789,574 | 205,426 | −8.87% | plan? |
| Jun 14, 2017 SForm 4 → | Jun 16, 5:41 pm EDT | Farah ChampsiDirector | 20,450 | $89.79 | $1,836,200 | 0 | −100% | plan? |
| Jun 9, 2017 SForm 4 → | Jun 12, 7:16 pm EDT | Cynthia M ButittaChief Operating Officer | 10,000 | $88.55 | $885,491 | 117,795 | −7.83% | plan? |
| Jun 9, 2017 MForm 4 → | Jun 12, 7:16 pm EDT | Cynthia M ButittaChief Operating Officer | 10,000 | $1.35 | $13,500 | 127,795 | — | plan? |
| Jun 7, 2017 SForm 4 → | Jun 9, 9:11 pm EDT | Roy DoumaniDirector | 15,000 | $84.48 | $1,267,255 | 150,017 | −9.09% | plan? |
| Jun 1, 2017 SForm 4 → | Jun 5, 5:05 pm EDT | Helen Susan KimEVP, Business Development | 2,400 | $72.45 | $173,880 | 18,664 | −11.4% | plan? |
| Jun 1, 2017 MForm 4 → | Jun 5, 5:05 pm EDT | Helen Susan KimEVP, Business Development | 2,400 | $51.43 | $123,432 | 21,064 | — | plan? |
| May 10, 2017 PForm 4 → | May 10, 3:12 pm EDT | Paul L JenkinsonChief Financial Officer | 3,450 | $72.59 | $250,427 | 3,000 | — | plan? |
| May 9, 2017 PForm 4 → | May 11, 2:02 pm EDT | Ran NussbaumDirector | 9,832 | $69.11 | $679,474 | 2,632 | — | plan? |
| May 9, 2017 PForm 4 → | May 10, 12:52 pm EDT | Steven B RuchefskyDirector | 1,400 | $69.50 | $97,300 | 225,426 | +0.62% | plan? |
| May 9, 2017 PForm 4 → | May 9, 6:29 pm EDT | David BondermanDirector | 50,000 | $68.94 | $3,446,998 | 2,408,084 | +2.12% | plan? |
| May 9, 2017 PForm 4 → | May 9, 3:37 pm EDT | Arie BelldegrunChairman, President and CEO, Director | 17,000 | $68.57 | $1,165,690 | 85,507 | +24.8% | plan? |
| May 1, 2017 SForm 4 → | May 3, 6:08 pm EDT | Helen Susan KimEVP, Business Development | 2,400 | $82.12 | $197,088 | 18,664 | −11.4% | plan? |
| May 1, 2017 MForm 4 → | May 3, 6:08 pm EDT | Helen Susan KimEVP, Business Development | 2,400 | $53.90 | $129,360 | 21,064 | — | plan? |
| May 1, 2017 SForm 4 → | May 3, 6:06 pm EDT | David D ChangEVP, R&D, Chief Medical Off. | 20,000 | $82.09 | $1,641,744 | 50,165 | −28.5% | plan? |
| May 1, 2017 MForm 4 → | May 3, 6:06 pm EDT | David D ChangEVP, R&D, Chief Medical Off. | 20,000 | $6.89 | $137,800 | 70,165 | — | plan? |
| Apr 27, 2017 SForm 4 → | May 1, 6:52 pm EDT | Farah ChampsiDirector | 19,168 | $82.75 | $1,586,064 | 4,962 | −79.4% | plan? |
| Apr 25, 2017 SForm 4 → | Apr 27, 6:49 pm EDT | Cynthia M ButittaChief Operating Officer | 15,000 | $81.85 | $1,227,690 | 117,795 | −11.3% | plan? |
| Apr 25, 2017 MForm 4 → | Apr 27, 6:49 pm EDT | Cynthia M ButittaChief Operating Officer | 15,000 | $1.35 | $20,250 | 132,795 | — | plan? |
| Apr 24, 2017 SForm 4 → | Apr 26, 5:38 pm EDT | Farah ChampsiDirector | 123,913 | $82.67 | $10,244,036 | 24,130 | −83.7% | plan? |
| Apr 13, 2017 SForm 4 → | Apr 17, 9:24 pm EDT | Farah ChampsiDirector | 115,376 | $82.42 | $9,509,766 | 148,043 | −43.8% | plan? |
| Apr 3, 2017 SForm 4 → | Apr 4, 4:17 pm EDT | David D ChangEVP, R&D, Chief Medical Off. | 20,000 | $81.54 | $1,630,866 | 50,165 | −28.5% | plan? |
| Apr 3, 2017 MForm 4 → | Apr 4, 4:17 pm EDT | David D ChangEVP, R&D, Chief Medical Off. | 20,000 | $6.89 | $137,800 | 70,165 | — | plan? |
| Apr 3, 2017 SForm 4 → | Apr 4, 4:16 pm EDT | Helen Susan KimEVP, Business Development | 2,400 | $81.80 | $196,320 | 18,664 | −11.4% | plan? |
| Apr 3, 2017 MForm 4 → | Apr 4, 4:16 pm EDT | Helen Susan KimEVP, Business Development | 2,400 | $53.90 | $129,360 | 21,064 | — | plan? |
| Apr 3, 2017 SForm 4 → | Apr 4, 4:15 pm EDT | Cynthia M ButittaChief Operating Officer | 5,000 | $81.96 | $409,798 | 117,795 | −4.07% | plan? |
| Apr 3, 2017 MForm 4 → | Apr 4, 4:15 pm EDT | Cynthia M ButittaChief Operating Officer | 5,000 | $1.35 | $6,750 | 122,795 | — | plan? |
| Mar 27, 2017 SForm 4 → | Mar 28, 7:57 pm EDT | Cynthia M ButittaChief Operating Officer | 10,000 | $77.67 | $776,746 | 117,795 | −7.83% | plan? |
| Mar 27, 2017 MForm 4 → | Mar 28, 7:57 pm EDT | Cynthia M ButittaChief Operating Officer | 10,000 | $1.35 | $13,500 | 127,795 | — | plan? |
| Mar 15, 2017 SForm 4 → | Sep 27, 9:42 pm EDT | Timothy L. MooreEVP, Technical Operations | 11,739 | $118.01 | $1,385,360 | 45,661 | −20.5% | plan? late |
| Mar 14, 2017 AForm 4 → | Mar 16, 5:13 pm EDT | Owen N. WitteDirector | 4,690 | — | — | 86,340 | — | plan? |
| Mar 9, 2017 SForm 4 → | Mar 10, 5:25 pm EST | Cynthia M ButittaChief Operating Officer | 21,118 | $80.78 | $1,705,929 | 117,795 | −15.2% | plan? |
| Mar 9, 2017 MForm 4 → | Mar 10, 5:25 pm EST | Cynthia M ButittaChief Operating Officer | 21,118 | $1.35 | $28,509 | 138,913 | — | plan? |
| Mar 1, 2017 SForm 4 → | Mar 2, 6:09 am EST | Jeffrey WiezorekSVP Clinical Development | 18,000 | $75.01 | $1,350,144 | 21,071 | −46.1% | plan? |
| Mar 1, 2017 MForm 4 → | Mar 2, 6:09 am EST | Jeffrey WiezorekSVP Clinical Development | 18,000 | $6.89 | $124,020 | 39,071 | — | plan? |
| Mar 1, 2017 SForm 4 → | Mar 2, 6:08 am EST | David D ChangEVP, R&D, Chief Medical Off. | 60,000 | $79.16 | $4,749,441 | 50,165 | −54.5% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 3, 2017 DForm 4 → | Oct 5, 8:28 pm EDT | Jonathan M PeacockDirector | 75,810 | $156.00 | $11,826,350 | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 5, 8:27 pm EDT | Ian T ClarkDirector | 25,940 | $118.68 | $3,078,516 | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 5, 8:26 pm EDT | Ran NussbaumDirector | 75,810 | $156.00 | $11,826,350 | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 5, 8:25 pm EDT | Joshua A KazamDirector | 75,810 | $156.00 | $11,826,350 | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 5, 8:24 pm EDT | Franz B HumerDirector | 35,810 | $116.27 | $4,163,750 | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 5, 8:23 pm EDT | Roy DoumaniDirector | 55,810 | $144.91 | $8,087,150 | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 5, 8:22 pm EDT | David BondermanDirector | 75,810 | $156.00 | $11,826,350 | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 5, 8:21 pm EDT | Steven B RuchefskyDirector | 275,810 | $172.90 | $47,686,350 | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 5, 8:20 pm EDT | Farah ChampsiDirector | 75,810 | $156.00 | $11,826,350 | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 5, 8:19 pm EDT | Owen N. WitteDirector | 65,940 | $119.91 | $7,907,004 | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 5, 8:17 pm EDT | Timothy L. MooreEVP, Technical Operations | 251,700 | $135.09 | $16,768,046 | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 5, 8:16 pm EDT | Shawn TomaselloChief Commercial Officer | 198,500 | $116.13 | $10,800,090 | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 5, 8:15 pm EDT | Jeffrey WiezorekSVP Clinical Development | 139,000 | $150.62 | $7,749,857 | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 5, 8:14 pm EDT | Helen Susan KimEVP, Business Development | 165,251 | $119.44 | $2,471,109 | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 5, 8:13 pm EDT | Paul L JenkinsonChief Financial Officer | 149,200 | $134.96 | $5,623,243 | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 5, 8:12 pm EDT | David D ChangEVP, R&D, Chief Medical Off. | 404,700 | $152.97 | $30,171,082 | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 5, 8:11 pm EDT | Cynthia M ButittaChief Operating Officer | 461,605 | $152.97 | $37,641,492 | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 5, 8:10 pm EDT | Arie BelldegrunChairman, President and CEO, Director | 399,600 | $124.29 | $17,369,767 | 0 | — | |
| Aug 10, 2017 MForm 4 → | Aug 14, 5:04 pm EDT | Helen Susan KimEVP, Business Development | 6,251 | — | — | 37,344 | — | |
| Aug 10, 2017 MForm 4 → | Aug 14, 5:03 pm EDT | Cynthia M ButittaChief Operating Officer | 15,000 | — | — | 80,394 | — | |
| Aug 8, 2017 MForm 4 → | Aug 10, 4:57 pm EDT | Helen Susan KimEVP, Business Development | 79,949 | — | — | 60,002 | — | |
| Aug 3, 2017 MForm 4 → | Aug 4, 7:50 pm EDT | Timothy L. MooreEVP, Technical Operations | 6,000 | — | — | 146,000 | — | |
| Aug 1, 2017 MForm 4 → | Aug 3, 9:14 pm EDT | Timothy L. MooreEVP, Technical Operations | 3,000 | — | — | 152,000 | — | |
| Jul 31, 2017 MForm 4 → | Aug 1, 7:00 pm EDT | Helen Susan KimEVP, Business Development | 26,649 | — | — | 139,951 | — | |
| Jul 10, 2017 MForm 4 → | Jul 11, 5:36 pm EDT | Cynthia M ButittaChief Operating Officer | 15,000 | — | — | 95,394 | — | |
| Jul 3, 2017 MForm 4 → | Jul 6, 6:15 pm EDT | Jeffrey WiezorekSVP Clinical Development | 10,000 | — | — | 58,000 | — | |
| Jun 23, 2017 MForm 4/A → | Jun 27, 7:07 pm EDT | Cynthia M ButittaChief Operating Officer | 5,000 | — | — | 110,394 | — | |
| Jun 23, 2017 MForm 4 → | Jun 26, 7:55 pm EDT | Owen N. WitteDirector | 12,500 | — | — | 0 | — | |
| Jun 20, 2017 AForm 4 → | Jun 22, 2:49 pm EDT | Farah ChampsiDirector | 8,810 | — | — | 8,810 | — | |
| Jun 20, 2017 AForm 4 → | Jun 22, 2:48 pm EDT | David BondermanDirector | 8,810 | — | — | 8,810 | — | |
| Jun 20, 2017 AForm 4 → | Jun 22, 2:47 pm EDT | Ian T ClarkDirector | 8,810 | — | — | 8,810 | — | |
| Jun 20, 2017 AForm 4 → | Jun 22, 2:44 pm EDT | Roy DoumaniDirector | 8,810 | — | — | 8,810 | — | |
| Jun 20, 2017 AForm 4 → | Jun 22, 2:39 pm EDT | Franz B HumerDirector | 8,810 | — | — | 8,810 | — | |
| Jun 20, 2017 AForm 4 → | Jun 22, 2:38 pm EDT | Joshua A KazamDirector | 8,810 | — | — | 8,810 | — | |
| Jun 20, 2017 AForm 4 → | Jun 22, 2:37 pm EDT | Ran NussbaumDirector | 8,810 | — | — | 8,810 | — | |
| Jun 20, 2017 AForm 4 → | Jun 22, 2:35 pm EDT | Steven B RuchefskyDirector | 8,810 | — | — | 8,810 | — | |
| Jun 20, 2017 AForm 4 → | Jun 22, 2:34 pm EDT | Jonathan M PeacockDirector | 8,810 | — | — | 8,810 | — | |
| Jun 20, 2017 AForm 4 → | Jun 22, 2:33 pm EDT | Owen N. WitteDirector | 8,810 | — | — | 8,810 | — | |
| Jun 9, 2017 MForm 4 → | Jun 12, 7:16 pm EDT | Cynthia M ButittaChief Operating Officer | 10,000 | — | — | 115,394 | — | |
| Jun 1, 2017 MForm 4 → | Jun 5, 5:05 pm EDT | Helen Susan KimEVP, Business Development | 2,400 | — | — | 50,099 | — | |
| May 1, 2017 MForm 4 → | May 3, 6:08 pm EDT | Helen Susan KimEVP, Business Development | 2,400 | — | — | 156,501 | — | |
| May 1, 2017 MForm 4 → | May 3, 6:06 pm EDT | David D ChangEVP, R&D, Chief Medical Off. | 20,000 | — | — | 123,000 | — | |
| Apr 25, 2017 MForm 4 → | Apr 27, 6:49 pm EDT | Cynthia M ButittaChief Operating Officer | 15,000 | — | — | 125,394 | — | |
| Apr 3, 2017 MForm 4 → | Apr 4, 4:17 pm EDT | David D ChangEVP, R&D, Chief Medical Off. | 20,000 | — | — | 143,000 | — | |
| Apr 3, 2017 MForm 4 → | Apr 4, 4:16 pm EDT | Helen Susan KimEVP, Business Development | 2,400 | — | — | 158,901 | — | |
| Apr 3, 2017 MForm 4 → | Apr 4, 4:15 pm EDT | Cynthia M ButittaChief Operating Officer | 5,000 | — | — | 140,394 | — | |
| Mar 27, 2017 MForm 4 → | Mar 28, 7:57 pm EDT | Cynthia M ButittaChief Operating Officer | 10,000 | — | — | 145,394 | — | |
| Mar 14, 2017 AForm 4 → | Mar 16, 5:13 pm EDT | Owen N. WitteDirector | 17,130 | — | — | 17,130 | — | |
| Mar 9, 2017 MForm 4 → | Mar 10, 5:25 pm EST | Cynthia M ButittaChief Operating Officer | 21,118 | — | — | 155,394 | — | |
| Mar 1, 2017 MForm 4 → | Mar 2, 6:09 am EST | Jeffrey WiezorekSVP Clinical Development | 18,000 | — | — | 68,000 | — | |
| Mar 1, 2017 MForm 4 → | Mar 2, 6:08 am EST | David D ChangEVP, R&D, Chief Medical Off. | 60,000 | — | — | 163,000 | — | |
| Mar 1, 2017 MForm 4 → | Mar 2, 6:06 am EST | Roy DoumaniDirector | 50,000 | — | — | 75,065 | — | |
| Feb 28, 2017 MForm 4 → | Mar 2, 6:05 am EST | Helen Susan KimEVP, Business Development | 50,300 | — | — | 161,301 | — | |
| Feb 27, 2017 MForm 4 → | Mar 1, 9:59 pm EST | Cynthia M ButittaChief Operating Officer | 38,882 | — | — | 176,512 | — | |
| Feb 1, 2017 MForm 4 → | Feb 6, 4:36 pm EST | Jeffrey WiezorekSVP Clinical Development | 1,500 | — | — | 86,000 | — | late |
| Jan 31, 2017 MForm 4 → | Feb 1, 7:09 pm EST | Cynthia M ButittaChief Operating Officer | 10,000 | — | — | 215,394 | — | |
| Jan 6, 2017 MForm 4 → | Jan 10, 5:04 pm EST | Jeffrey WiezorekSVP Clinical Development | 1,500 | — | — | 87,500 | — | |
| Jan 6, 2017 MForm 4 → | Jan 10, 5:03 pm EST | Cynthia M ButittaChief Operating Officer | 10,000 | — | — | 225,394 | — | |
| Jan 3, 2017 AForm 4 → | Jan 5, 4:56 pm EST | Ian T ClarkDirector | 17,130 | — | — | 17,130 | — | |
| Dec 27, 2016 AForm 4 → | Dec 29, 5:50 pm EST | Arie BelldegrunChairman, President and CEO, Director | 159,700 | — | — | 159,700 | — | |
| Dec 22, 2016 AForm 4 → | Dec 27, 5:37 pm EST | Shawn TomaselloChief Commercial Officer | 38,500 | — | — | 38,500 | — | |
| Dec 22, 2016 AForm 4 → | Dec 27, 5:36 pm EST | Timothy L. MooreEVP, Technical Operations | 30,700 | — | — | 30,700 | — | |
| Dec 22, 2016 AForm 4 → | Dec 27, 5:34 pm EST | Jeffrey WiezorekSVP Clinical Development | 38,500 | — | — | 38,500 | — | |
| Dec 22, 2016 AForm 4 → | Dec 27, 5:33 pm EST | Paul L JenkinsonChief Financial Officer | 24,200 | — | — | 24,200 | — | |
| Dec 22, 2016 AForm 4 → | Dec 27, 5:29 pm EST | Helen Susan KimEVP, Business Development | 38,500 | — | — | 38,500 | — | |
| Dec 22, 2016 AForm 4 → | Dec 27, 5:28 pm EST | David D ChangEVP, R&D, Chief Medical Off. | 90,600 | — | — | 90,600 | — | |
| Dec 22, 2016 AForm 4 → | Dec 27, 5:21 pm EST | Cynthia M ButittaChief Operating Officer | 90,600 | — | — | 90,600 | — | |
| Nov 25, 2016 MForm 4 → | Nov 29, 5:02 pm EST | Cynthia M ButittaChief Operating Officer | 10,000 | — | — | 235,394 | — | |
| Nov 10, 2016 MForm 4 → | Dec 5, 7:03 pm EST | Jeffrey WiezorekSVP Clinical Development | 1,500 | — | — | 89,000 | — | late |
| Nov 10, 2016 MForm 4 → | Nov 14, 6:57 pm EST | Cynthia M ButittaChief Operating Officer | 10,000 | — | — | 245,394 | — | |
| Nov 10, 2016 MForm 4 → | Nov 14, 6:55 pm EST | Jeffrey WiezorekSVP Clinical Development | 1,500 | — | — | 76,208 | — | |
| Oct 3, 2016 MForm 4 → | Oct 5, 7:44 pm EDT | Jeffrey WiezorekSVP Clinical Development | 1,500 | — | — | 77,708 | — | |
| Sep 26, 2016 MForm 4 → | Sep 28, 5:03 pm EDT | Cynthia M ButittaChief Operating Officer | 10,000 | — | — | 255,394 | — | |
| Sep 1, 2016 MForm 4 → | Sep 2, 6:34 pm EDT | Jeffrey WiezorekSVP Clinical Development | 1,500 | — | — | 79,208 | — | |
| Aug 25, 2016 MForm 4 → | Aug 26, 6:38 pm EDT | Cynthia M ButittaChief Operating Officer | 10,000 | — | — | 265,394 | — | |
| Aug 1, 2016 MForm 4 → | Aug 2, 6:51 pm EDT | Jeffrey WiezorekSVP Clinical Development | 1,500 | — | — | 80,708 | — | |
| Jul 25, 2016 MForm 4 → | Jul 26, 7:03 pm EDT | Cynthia M ButittaChief Operating Officer | 10,000 | — | — | 275,394 | — | |
| Jul 1, 2016 MForm 4 → | Jul 5, 6:27 pm EDT | Jeffrey WiezorekSVP Clinical Development | 1,500 | — | — | 82,208 | — | |
| Jun 23, 2016 MForm 4 → | Jun 27, 7:08 pm EDT | Cynthia M ButittaChief Operating Officer | 20,000 | — | — | 285,394 | — | |
| Jun 1, 2016 AForm 4 → | Jun 3, 7:20 pm EDT | Farah ChampsiDirector | 7,000 | — | — | 7,000 | — | |
| Jun 1, 2016 AForm 4 → | Jun 3, 7:15 pm EDT | Franz B HumerDirector | 7,000 | — | — | 7,000 | — | |
| Jun 1, 2016 AForm 4 → | Jun 3, 7:15 pm EDT | Jonathan M PeacockDirector | 7,000 | — | — | 7,000 | — | |
| Jun 1, 2016 AForm 4 → | Jun 3, 7:14 pm EDT | Roy DoumaniDirector | 7,000 | — | — | 7,000 | — | |
| Jun 1, 2016 AForm 4 → | Jun 3, 7:13 pm EDT | Ran NussbaumDirector | 7,000 | — | — | 7,000 | — | |
| Jun 1, 2016 AForm 4 → | Jun 3, 7:12 pm EDT | Joshua A KazamDirector | 7,000 | — | — | 7,000 | — | |
| Jun 1, 2016 AForm 4 → | Jun 3, 7:11 pm EDT | David BondermanDirector | 7,000 | — | — | 7,000 | — | |
| Jun 1, 2016 AForm 4 → | Jun 3, 7:10 pm EDT | Steven B RuchefskyDirector | 7,000 | — | — | 7,000 | — | |
| May 31, 2016 MForm 4 → | Jun 2, 5:15 pm EDT | Jeffrey WiezorekSVP Clinical Development | 3,000 | — | — | 83,708 | — | |
| May 16, 2016 AForm 4 → | May 18, 5:08 pm EDT | Paul L JenkinsonChief Financial Officer | 125,000 | — | — | 125,000 | — | |
| Apr 4, 2016 MForm 4 → | Apr 6, 7:06 pm EDT | Cynthia M ButittaCOO and CFO | 10,000 | — | — | 305,394 | — | |
| Mar 15, 2016 MForm 4 → | Mar 17, 9:15 pm EDT | Jeffrey WiezorekSVP Clinical Development | 9,000 | — | — | 86,708 | — | |
| Mar 15, 2016 MForm 4 → | Mar 17, 9:15 pm EDT | Rizwana F SprouleVP Regulatory Affairs | 8,500 | — | — | 95,830 | — | |
| Mar 15, 2016 MForm 4 → | Mar 17, 9:14 pm EDT | Margo R RobertsChief Scientific Officer | 8,506 | — | — | 30,575 | — | |
| Mar 15, 2016 AForm 4 → | Mar 16, 8:16 pm EDT | Timothy L. MooreEVP, Technical Operations | 230,000 | — | — | 75,000 | — | |
| Mar 1, 2016 MForm 4 → | Mar 3, 7:13 pm EST | Cynthia M ButittaCOO and CFO | 10,000 | — | — | 315,394 | — | |
| Feb 17, 2016 MForm 4/A → | Mar 17, 9:13 pm EDT | Margo R RobertsChief Scientific Officer | 9,632 | — | — | 31,581 | — | |
| Feb 17, 2016 MForm 4 → | Feb 19, 4:14 pm EST | Margo R RobertsChief Scientific Officer | 9,632 | — | — | 62,743 | — | amended |
| Feb 17, 2016 MForm 4 → | Feb 19, 4:13 pm EST | Rizwana F SprouleVP Regulatory Affairs | 9,567 | — | — | 104,330 | — | |
| Feb 12, 2016 MForm 4 → | Feb 16, 7:05 pm EST | Margo R RobertsChief Scientific Officer | 18,750 | — | — | 72,375 | — | |
| Feb 2, 2016 MForm 4 → | Feb 4, 9:06 pm EST | Cynthia M ButittaCOO and CFO | 1,900 | — | — | 325,394 | — |